Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutation in Cancer Predisposition Genes

NCT02705846 is registered in ClinicalTrials.gov with Institute of Cancer Research, United Kingdom as lead sponsor.

NCT NCT02705846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02705846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutation in Cancer Predisposition Genes
Lead sponsor
Institute of Cancer Research, United Kingdom
Phase
Observational
Overall status
Recruiting
Start date
September 30, 2014
Completion date
December 31, 2035
Enrollment
4,260 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer